An evaluation of the impact of a community-based adherence support programme on ART outcomes in selected government HIV treatment sites in South Africa

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 23, Issue 2, 2011, Pages 231-236

  Igumbor, J O ^a   Scheepers, E ^b   Ebrahim, R ^c   Jason, A ^b   Grimwood, A ^b  

^a NORTH WEST UNIVERSITY   (South Africa)

^b Kheth'Impilo   (South Africa)

^c Monitor Group   (United Kingdom)

Author keywords

adherence; AIDS; antiretroviral therapy (ART); community based support; HIV; patient advocates (PA)

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HEALTH CARE FACILITY; HEALTH PROGRAM; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SOCIAL SUPPORT; SOUTH AFRICA; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; COMMUNITY HEALTH SERVICES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SOUTH AFRICA; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 79251515177     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2010.498909     Document Type: Article

References (19)

1. Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Robertson, M., & Zolopa, A. R. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15, 1181-1183.
2. Battaglioli-DeNero, A. M. (2007). Strategies for improving patient adherence to therapy and long term patient outcomes. Journal of the Association of Nurses in AIDS Care, 18 (1S), S17-S22.
3. Chesney, M. (2003). Adherence to HAART regimens. AIDS Patient Care and STDs, 17, 169-177.
4. Garcia, P., Knobel, H., Carmona, A., Guelar, A., Lopez-Colomes, J. L., & Cayla, J. A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndrome, 30, 105-110.
5. Golin, C. E., Liu, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J., &... Wenger, N. S. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17, 756-765.
6. Grossberg, R., & Gross, R. (2007). Use of pharmacy refill data as a measure of antiretroviral adherence. Current HIV/AIDS Reports, 4(4), 187-191.
7. Grossberg, R., Zhang, Y., & Gross, R. (2004). A time-toprescription- refill measure of antiretroviral adherence predicted changes in viral load in HIV. Journal of Clinical Epidemiology, 57, 1107-1110.
8. Hogg, R. S., Heath, K., Bangsberg, D., Yip, B., Press, N., O'Shaughnessy, M. V., & Montaner, J. S. (2002). Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS, 16, 1051-1058.
9. Holzemer, W. L., Bakken, S., Portillo, C., Grimes, R., Welch, J., Wantland, D., & Mullan, J. T. (2006). Testing a nurse-tailored HIV medication adherence intervention. Nursing Research, 55(3), 189-197.
10. Knobel, H., Guelar, A., & Carmona, A. (2001). Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors. AIDS Patient Care STD, 15, 193-199.
11. Lichtenstein, K. A. (2005). Redefining lipodystrophy syndrome: Risks and impact on clinical decision making. Journal of Acquired Immune Deficiency Syndromes, 39, 395-400.
12. Liu, H., Golin, C. E., & Miller, L. G. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968-977.
13. Palella, F. J., Deloria-Knoll, M., Chimiel, J. S., Moorman, A. C., Wood, K. C., & Greenberg, A. E. (2003). Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Annals of Internal Medicine, 138, 620-626.
14. Pradier, C., Bentz, L., Spire, B., Tourette-Turgis, C., Morin, M., & Souville, M. (2003). Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clinical Trials, 4(2), 121-131.
15. Rathbun, R., Farmer, K., & Stephens, J. (2004, February 8-11). Impact of an adherence clinic on behavioral outcomes and virologic response: Results from a prospective, randomized, controlled pilot study. Program and abstracts of the 11th conference on retroviruses and opportunistic infections, San Francisco, CA. (Abstract 562)
16. Simoni, J. M., Frick, P. A., Pantalone, D. W., & Turner, B. J. (2003). Antiretroviral adherence interventions: A review of current literature and ongoing studies. Topics in HIV Medicine, 11(6), 185-198.
17. Tuldra, A., Fumaz, C. R., Ferrer, M. J., Bayes, R., Arno, A., Balague, M.,... Clotet, B. (2000). Prospective randomized two-arm controlled study to determine the efficacy of a special intervention to improve longterm adherence to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 25, 221-228.
18. Walmsley, S., Bernstein, B., King, M., Arribas, J., Beall, G., & Ruane, P. (2002). Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. The New England Journal of Medicine, 346, 2039-2046.
19. Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O'Shaughnessy, M. V., & Montaner, J. S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Annals of Internal Medicine, 139, 810-816.